Requires Medicaid coverage for continuous glucose monitors and related supplies for individuals diagnosed with diabetes who meet certain coverage eligibility criteria.

This bill requires New Jersey's Medicaid program to cover continuous glucose monitors (CGMs) and related supplies for individuals diagnosed with diabetes who meet specific eligibility criteria. To qualify, recipients must be treated with insulin or have documented history of severe hypoglycemia (two or more episodes below 54 mg/dL requiring third-party assistance, or one episode causing altered mental state). The coverage requires CGMs to be prescribed according to FDA-approved indications, recipients must demonstrate proper training in device use, and beneficiaries must participate in regular follow-up care with healthcare providers (at least once every six months for 18 months, then annually). The bill directs the Commissioner of Human Services to seek necessary federal approvals to implement this coverage. This change would directly affect Medicaid recipients with diabetes who rely on CGMs for blood glucose management.